Preview

Biosafety and Biotechnology

Advanced search

PRODUCTION SERIES OF INACTIVATED AVIAN INFLUENZA VACCINE MADE OF RECOMBINANT STRAIN RG43A (H5N8) SAFETY AND IMMUNOGENICITY TESTING

Abstract

The paper presents the results of determining the safety and immunogenicity of the production series of the avian influenza inactivated vaccine made of the new recombinant strain A/gyrfalcon/Washington/41088-6/2014 (H5N8)-PR8-IDCDC-RG43A, hereinafter abbreviated RG43A (H5N8), prepared according to previously developed technology. The vaccine is safe with intramuscular administration of a five-fold dose of 2,5 cm3 for chickens of 88 days age. The vaccine is immunogenic when administered intramuscularly at a dose of 0,5 cm3, the average titers of antibodies to the avian influenza virus subtype H5 on the 28th day after administration of the drug were 1:224. Studies have established the immunogenic capabilities of the vaccine from the recombinant strain. The results of the experiments showed the advantage of using a recombinant strain adapted to embryos instead of the field avian influenza virus subtype H5.

About the Authors

Zh. Kydyrbayev
RGE «Research Institute for Biological Safety Problems»
Kazakhstan


N. N. Assanzhanova
RGE «Research Institute for Biological Safety Problems»
Kazakhstan


A. S. Nurpeisova
RGE «Research Institute for Biological Safety Problems»
Kazakhstan


E. K. Kulbekov
RGE «Research Institute for Biological Safety Problems»
Kazakhstan


E. T. Myrzakhmetov
RGE «Research Institute for Biological Safety Problems»
Kazakhstan


N. Zh. Akmyrzayev
RGE «Research Institute for Biological Safety Problems»
Kazakhstan


Zh. A. Tursynova
RGE «Research Institute for Biological Safety Problems»
Kazakhstan


References

1. Кыдырбаев Ж.К., Табынов К.К., Хайруллин Б.М. Высокопатогенный грипп птиц: Распространение в Казахстане и разработка средств специфической профилактики // «Асыл кітап». – Алматы, 2015. – 356 с.

2. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness // World Health Organization, 28 September, 2017. – 2017.

3. https://kazakh-zerno.net/127932-v-mire-nablyudaetsya-tendentsiya-k-rostu-vspyshek-grippa-udomashnikh-ptits/

4. https://inbusiness.kz/ru/last/ptichij-gripp-v-kazahstane-chto-nado-znat-o-zabolevanii

5. Swayne D.E., Kapczynski D. Vaccines, vaccination and immunology for avian influenza viruses in poultry. In: Swayne D.E.., ed. Avian Influenza. Ames, Iowa: Blackwell Publishers; – 2008: 407-52.

6. Нурпейсова А.С., Кыдырбаев Ж., Касенов М.М., Асанжанова Н.Н., Инкарбеков Д.А., Хайруллин Б.М., Закарья К.Д. Приготовление опытно-промышленных серий вакцин из актуальных штаммов гриппа птиц // Тезисы доклада на VI Международной конференции молодых ученых биофизиков, биотехнологов, молекулярных биологов и вирусологов. Сборник тезисов АНО «Инновационный Центр Кольцово». – Новосибирск ИПЦ НГУ, 2019. – № 3. – С 374.

7. Mailybayeva A., Nurpeisova A.S., Assanzhanova N.N., Kozhamkulov Y.M., Inkarbekov D.A., Abitaev R.T., Jekebekov K.K., Nurabayev S.Sh., Kassenov M.M., Khairullin B.M., Kydyrbayev Zh., Valdovska A., Zakarya K.D. Optimization of cultivation condition of subtype H5 flu virus // «Вестник НАН РК». – 2020. – № 6. – С 71.

8. Kydyrbayev Z., Tabynov K., Ryskeldynova S., Mamadaliyev S., Khairullin B. Immunogenicity of the inactivated oil emulsion influenza A(H5N1) vaccine in chickens. Agriculture and Biologi Journal of North America. – 2010, – Р. 201-207


Review

For citations:


Kydyrbayev Zh., Assanzhanova N.N., Nurpeisova A.S., Kulbekov E.K., Myrzakhmetov E.T., Akmyrzayev N.Zh., Tursynova Zh.A. PRODUCTION SERIES OF INACTIVATED AVIAN INFLUENZA VACCINE MADE OF RECOMBINANT STRAIN RG43A (H5N8) SAFETY AND IMMUNOGENICITY TESTING. Biosafety and Biotechnology. 2021;(8):6-12. (In Russ.)

Views: 1063


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2707-7241 (Print)
ISSN 2957-5702 (Online)